Navigation

Search the NICE 'do not do' recommendations database

You can search the NICE 'do not do' recommendations database by:

  • typing in a specific term in the 'do not do' recommendations box
  • selecting an appropriate topic
  • selecting the type of source guidance.

To see the full list of all NICE 'do not do' recommendations leave all the fields blank and click the 'Search' button.

Attention deficit hyperactivity disorder (ADHD)

Guidance ID NICE 'do not do' recommendation Interventions
CG72 Universal screening for attention deficit hyperactivity disorder (ADHD) should not be undertaken in nursery, primary and secondary schools. universal screening
CG72 Primary care practitioners should not make the initial diagnosis or start drug treatment in children or young people with suspected attention deficit hyperactivity disorder (ADHD). diagnosis or drug treatment
CG72 A diagnosis of attention deficit hyperactivity disorder (ADHD) should not be made solely on the basis of rating scale or observational data. However rating scales such as the Conners rating scales and the Strengths and Difficulties questionnaire are valuable adjuncts, and observations (for example, at school) are useful when there is doubt about symptoms. rating scale or observational data based diagnosis
CG72 Dietary fatty acid supplementation is not recommended for the treatment of Attention deficit hyperactivity disorder (ADHD) in children and young people. fatty acid supplements
CG72 Drug treatment is not recommended for pre-school children with attention deficit hyperactivity disorder (ADHD). drug treatment
CG72 Antipsychotics are not recommended for the treatment of attention deficit hyperactivity disorder (ADHD) in children and young people. antipsychotics
CG72 Antipsychotics are not recommended for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. antipsychotics
CG72 For people taking methylphenidate, dexamfetamine and atomoxetine, routine blood tests and electrocardiograms (ECGs) are not recommended unless there is a clinical indication. blood tests and electrocardiograms (ECGs)
CG72 Liver damage is a rare and idiosyncratic adverse effect of atomoxetine and routine liver function tests are not recommended. routine liver function tests
CG72 Drug treatment is not indicated as the first-line treatment for all school-age children and young people with attention deficit hyperactivity disorder (ADHD). drug treatment

Back to ´do not do´ recommendations home

This page was last updated: 28 March 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.